Medicines distribution in Romania in the context of global market

摘要

The medicine definitions differ from a country to another; finding a certain definition to be appropriate for the analysis from the perspective of the thematic issue of the present paper has become a necessity. As a first defining characteristic, it has to be pointed out that the medicine is not like the other commodities. It is meant for the most intimate human needs, thus affecting the quality of life, welfare, but also malady, death or human being cure (J.P. Buisson si D. Giorgi, 1997). Consequently, the medicine may be assimilated to a public cvasi-commodity (or under trusteeship), a fact proved by the public authorities attitude which include it into the political or sanitary (D. Richard si J. L. Senon, 1996) and establish organizations to control the supply and demand of medicines. This definition emphasizes the fact that the medicine offer is under trusteeship and regulated throughout the entire chain of value, at least on five levels: 1. Research (research labs must be in accordance with a certain number of international regulations), 2. Manufacturing (production process must respect the 'Good practices of production), 3. Marketing authorization released by the trusteeship authority, 4. Medicine including into its category of accessibility and 5. Medical staff which becomes the real decision maker with regard to medicine administration. All these regulations imposed internationally and supported by OMS influence considerably the medicine production and distribution. That is why the analysis of medicine distribution on a national market cannot be done without taking into account the international market characteristics. In such perspective, the present paper was structured in three sections: (1) Characteristics of medicines global (2) Organizing the system for distribution of medicine in Romania (3) New challenges of distribution of medicinal in Romania